Bioengineering edible mycelium to enhance nutritional value, color, and flavor

En­tra­da Ther­a­peu­tics an­nounced that it com­plet­ed dos­ing for two co­horts for a Phase I study of an ex­per­i­men­tal Duchenne mus­cu­lar dy­s­tro­phy drug that it’s con­duct­ing

From a ba­by’s first eye ex­am to ag­ing peo­ples’ cataracts, J&J Vi­sion’s newest cor­po­rate cam­paign nav­i­gates a life­time of eye health through the lens of